Bjarke Henric Bjorn
- SEC CIK
- 0001652179
No open-market purchases or sales filed in the past year.
Current role at each company
- INZY Inozyme Pharma, Inc.SVP, COOas of Dec 19, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bjarke Henric Bjorn as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Bjarke Henric BjornSVP, COO | PPurchase | +21.5K | $1.39 | +$29.9K | +25.6%105.4K after | |
| Apr 20, 2022 (view filing) | Apr 19 | 1 day | Bjarke Henric BjornSVP, COO | PPurchase | +27.1K | $3.69 | +$100.0K | +50.6%80.6K after |